1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Technology appraisal guidance [TA221] Published date: 27 April 2011 Last updated: 26 October 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Review decision
  • Review decision – November 2018
  • Review decision paper 09 November 2018   PDF 309.89 KB
  • Matrix of stakeholders 09 November 2018   PDF 255.67 KB